The globally accepted classification of BC is based on immunohistochemical analysis that categorises BC in relation to the expression of oestrogen (ER), progesterone (PR) and human epidermal growth factor receptor 2 (HER2) receptors in BC cells [1, 2]. This evidence concerns the gene PGR and breast cancer.